腹腔镜袖状胃切除术治疗肥胖患者经前期综合征症状
本病例对照研究于2018年3月至2022年3月前瞻性纳入131例BMI≥27.5 kg/cm²且诊断为中重度经前期综合征(PMS)的肥胖患者,由患者自行选择接受腹腔镜袖状胃切除术(LSG,68例)或不手术对照(63例),基线及治疗后3个月记录数据。LSG组PMS改善率为57.35%(n=39),对照组为25.40%(n=16);多因素分析显示手术是PMS改善的独立因素,酒精使用、2型糖尿病及肥胖相关代谢疾病、BMI与PMS相关,BMI、睾酮和雌二醇(E2)变化也可能促进改善。
要点
- LSG组PMS改善率为57.35%(n=39),对照组为25.40%(n=16)。
- 手术是肥胖合并PMS患者PMS改善的独立因素。
- BMI、睾酮和E2水平的变化可能促进肥胖合并PMS患者的改善。
核心结论
- LSG可在一定程度上改善肥胖合并PMS患者的肥胖管理。
- BMI、睾酮和E2的变化可能提示肥胖合并PMS患者的改善。
研究设计与样本
- 病例对照研究,2018年3月至2022年3月前瞻性选取131例BMI≥27.5 kg/cm²且诊断为中重度PMS的肥胖患者,由患者自行决定是否接受LSG。
- 68例选择LSG手术,63例对照组不手术仅随访,基线及治疗后3个月记录数据,采用多因素分析评估PMS症状改善及相关因素。
主要发现
- LSG组PMS改善率为57.35%(n=39),对照组PMS改善率为25.40%(n=16)。
- 手术是影响PMS患者改善的独立因素。
- 酒精使用、2型糖尿病及肥胖相关代谢疾病、BMI与PMS存在相关性。
- BMI、睾酮和E2水平的变化也可能促进肥胖合并PMS患者的改善。
关键数值与推荐
- PMS严重程度由参与者使用经前期综合征筛查工具自报。
- 肥胖定义为BMI≥27.5 kg/cm²。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Premenstrual syndrome (PMS) is a pathological condition characterized by a series of abnormal physical, psychological, and behavioral symptoms. We evaluated the effectiveness of laparoscopic sleeve gastrectomy (LSG) in the treatment of patients with obesity and PMS. METHODS: In this case-control study, 131 patients with obesity (BMI ≥ 27.5 kg/cm2) diagnosed with moderate-to-severe PMS from March 2018 to March 2022 were prospectively selected to undergo LSG or not at their own discretion. Participants self-reported their PMS severity using the Premenstrual Syndrome Screening Tool. Among them, 68 patients chose LSG surgery, and 63 control group patients were followed up without surgery. Data were recorded at baseline and at 3 months post-treatment. We used a multivariate analysis to assess the improvement in PMS symptoms and associated factors. RESULTS: Of the 131 patients with obesity and PMS, the improvement rate of PMS in the LSG group was 57.35% (n = 39), while the improvement rate of PMS in the control group was 25.40% (n = 16). Furthermore, our study revealed that surgery is an independent factor affecting the improvement of patients with PMS. Additionally, there was a correlation between alcohol use, T2DM and obesity-related metabolic diseases, and BMI with PMS. The changes in BMI, testosterone, and estradiol(E2) levels may also contribute to the improvement of patients with obesity and PMS. CONCLUSION: LSG can improve the management of obesity in patients with PMS to some extent. Changes in BMI, testosterone, and E2 may be indicative of improvement in patients with obesity and PMS.
引用
- Kong X, Zhang Y, Song K, et al. Laparoscopic sleeve gastrectomy for premenstrual syndrome symptoms in patients with obesity. Surg Endosc. 2024. PMID: 38622225. doi:10.1007/s00464-024-10819-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。